August 1, 2018 7:34am

The proximity to Q2 financial reporting and results will affect share pricing; between today and 8/9, there are 19 companies (of 45 covered) reporting their operational spending, cash positions, “run-ways” and hopefully some “clinical” guidance.

Pre-open indications: 3 BUYs on news, 1 SELL and 3 trades

 

Q2/18 earning’s alert: AxoGen (AXGN) and Intellia Therapeutics (NTLA)

 

RMi reports pre-open indications that shed light on share pricing events and today’s session values.

 

A trusted source of factual and sector reality reporting! Want to know WHY, subscribe!

 


Members only. Please login.